search

Smith & Nephew SNATS Inc (SNN)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Smith & Nephew guidance cut and weak wound care sales point to share fall, says Jefferies
Nov 5, 2026

Smith & Nephew guidance cut and weak wound care sales point to share fall, says Jefferies

Jefferies, the investment bank, expects shares in Smith & Nephew PLC to experience a short-term fall following weaker-than-expected third-quarter sales and a cut to the company's full-year guidance. The medical devices group reduced its organic sales growth guidance to about 3% from 4% and trading profit guidance to about $1.25 billion from $1.3 billion. Despite the expected short-term dip, Jefferies maintains a 'buy' rating and a 1,500p price target for the stock.
Company relevance
100.00%
Company sentiment
Bearish
Overall sentiment
Neutral